381 related articles for article (PubMed ID: 28714988)
1. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
Allen EK; Randolph AG; Bhangale T; Dogra P; Ohlson M; Oshansky CM; Zamora AE; Shannon JP; Finkelstein D; Dressen A; DeVincenzo J; Caniza M; Youngblood B; Rosenberger CM; Thomas PG
Nat Med; 2017 Aug; 23(8):975-983. PubMed ID: 28714988
[TBL] [Abstract][Full Text] [Related]
2. Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
David S; Correia V; Antunes L; Faria R; Ferrão J; Faustino P; Nunes B; Maltez F; Lavinha J; Rebelo de Andrade H
Immunogenetics; 2018 Mar; 70(3):169-177. PubMed ID: 28842783
[TBL] [Abstract][Full Text] [Related]
3. Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferon-inducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus.
Kim YC; Jeong BH
Immunogenetics; 2020 Dec; 72(9-10):447-453. PubMed ID: 33174121
[TBL] [Abstract][Full Text] [Related]
4. Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
Yang X; Tan B; Zhou X; Xue J; Zhang X; Wang P; Shao C; Li Y; Li C; Xia H; Qiu J
PLoS One; 2015; 10(5):e0124985. PubMed ID: 25942469
[TBL] [Abstract][Full Text] [Related]
5. The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
Cytokine; 2021 Jun; 142():155492. PubMed ID: 33711707
[TBL] [Abstract][Full Text] [Related]
6. IFITM3 affects the level of antibody response after influenza vaccination.
Lei N; Li Y; Sun Q; Lu J; Zhou J; Li Z; Liu L; Guo J; Qin K; Wang H; Zhao J; Li C; Sun L; Wang D; Zhao Z; Shu Y
Emerg Microbes Infect; 2020 Dec; 9(1):976-987. PubMed ID: 32321380
[TBL] [Abstract][Full Text] [Related]
7. IFITM3: How genetics influence influenza infection demographically.
Wellington D; Laurenson-Schafer H; Abdel-Haq A; Dong T
Biomed J; 2019 Feb; 42(1):19-26. PubMed ID: 30987701
[TBL] [Abstract][Full Text] [Related]
8. No Correlation of the Disease Severity of Influenza A Virus Infection with the rs12252 Polymorphism of the Interferon-Induced Transmembrane Protein 3 Gene.
Kim YC; Jeong BH
Intervirology; 2017; 60(1-2):69-74. PubMed ID: 28813716
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and SNP in IFITM3 are correlated with hand, foot and mouth disease caused by enterovirus 71.
Li M; Li YP; Deng HL; Wang MQ; Chen Y; Zhang YF; Wang J; Dang SS
Int J Infect Dis; 2021 Apr; 105():199-208. PubMed ID: 33596480
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Human
Martins JSC; Oliveira MLA; Garcia CC; Siqueira MM; Matos AR
Front Cell Infect Microbiol; 2020; 10():352. PubMed ID: 32754450
[TBL] [Abstract][Full Text] [Related]
11. Association of IFITM3 rs12252 polymorphisms, BMI, diabetes, and hypercholesterolemia with mild flu in an Iranian population.
Mehrbod P; Eybpoosh S; Fotouhi F; Shokouhi Targhi H; Mazaheri V; Farahmand B
Virol J; 2017 Nov; 14(1):218. PubMed ID: 29121968
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
Randolph AG; Yip WK; Allen EK; Rosenberger CM; Agan AA; Ash SA; Zhang Y; Bhangale TR; Finkelstein D; Cvijanovich NZ; Mourani PM; Hall MW; Su HC; Thomas PG; ;
J Infect Dis; 2017 Jul; 216(1):14-21. PubMed ID: 28531322
[TBL] [Abstract][Full Text] [Related]
13.
Pan Y; Yang P; Dong T; Zhang Y; Shi W; Peng X; Cui S; Zhang D; Lu G; Liu Y; Wu S; Wang Q
Front Cell Infect Microbiol; 2017; 7():294. PubMed ID: 28713779
[No Abstract] [Full Text] [Related]
14. IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis.
Xuan Y; Wang LN; Li W; Zi HR; Guo Y; Yan WJ; Chen XB; Wei PM
Epidemiol Infect; 2015 Oct; 143(14):2975-84. PubMed ID: 25778715
[TBL] [Abstract][Full Text] [Related]
15. High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults.
Qin L; Wang D; Li D; Zhao Y; Peng Y; Wellington D; Dai Y; Sun H; Sun J; Liu G; McMichael A; Dong T; Zhang Y
Front Cell Infect Microbiol; 2018; 8():134. PubMed ID: 29868492
[No Abstract] [Full Text] [Related]
16. IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
Lee N; Cao B; Ke C; Lu H; Hu Y; Tam CHT; Ma RCW; Guan D; Zhu Z; Li H; Lin M; Wong RYK; Yung IMH; Hung TN; Kwok K; Horby P; Hui DSC; Chan MCW; Chan PKS
J Infect Dis; 2017 Jul; 216(1):97-104. PubMed ID: 28510725
[TBL] [Abstract][Full Text] [Related]
17. Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis.
Prabhu SS; Chakraborty TT; Kumar N; Banerjee I
Gene; 2018 Oct; 674():70-79. PubMed ID: 29940276
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism between the Sorani and Hawrami kurdish populations and COVID-19 outcome.
Rashid PMA; Salih GF
Mol Biol Rep; 2023 Jun; 50(6):5177-5183. PubMed ID: 37119412
[TBL] [Abstract][Full Text] [Related]
19. Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
Makvandi-Nejad S; Laurenson-Schafer H; Wang L; Wellington D; Zhao Y; Jin B; Qin L; Kite K; Moghadam HK; Song C; Clark K; Hublitz P; Townsend AR; Wu H; McMichael AJ; Zhang Y; Dong T
J Infect Dis; 2018 Jan; 217(2):257-262. PubMed ID: 29202190
[TBL] [Abstract][Full Text] [Related]
20. Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.
Gaio V; Nunes B; Pechirra P; Conde P; Guiomar R; Dias CM; Barreto M
PLoS One; 2016; 11(6):e0158181. PubMed ID: 27351739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
